Form EFFECT AEON Biopharma, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 17, 2026 5:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AEON Biopharma, Inc (AEON) PT Raised to $2 at Lake Street
- Tribun Health Expands into Australia as CaloPix(R) 6.2.0 Is Included in the ARTG
- Entrée Resources Addresses Questions Raised in Plenary Session of Parliament of Mongolia
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share